Cancer Family
Esophageal Neoplasm
CI-CAN-00000174Explore in graph →
Non-malignant555 active trials6 approved drugs12 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000174Explore in graph →
Clinical trials
2,208 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03430843 | A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma | completed | Phase 3 | 512 | BeiGeneINDUSTRY | 11 | Oct 26, 2024 | clinicaltrials |
| NCT03469557 | BGB A317 in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Carcinoma | completed | Phase 2 | 30 | BeiGeneINDUSTRY | 1 | Oct 23, 2024 |
| NCT05611658 | Inter-observer Variation in Gross Tumor Delineation of Esophageal Cancer on MR, CT and PET CT | completed | — | 23 | Institute of Oncology LjubljanaOTHER | 1 | Oct 17, 2024 | clinicaltrials |
| NCT03189719 | First-line Esophageal Carcinoma Study With Pembrolizumab Plus Chemo vs. Chemo (MK-3475-590/KEYNOTE-590) | completed | Phase 3 | 749 | Merck Sharp & Dohme LLCINDUSTRY | 26 | Oct 15, 2024 | clinicaltrials |
| NCT05369234 | Effects of Oral Aloe Vera Juice on Chemotherapy and Radiation-induced Oral Mucositis and Esophagitis | completed | Phase 3 | 100 | Covenant Health Cancer CenterOTHER | 1 | Oct 10, 2024 | clinicaltrials |
| NCT03565003 | A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China | completed | Phase 1 / Phase 2 | 126 | Jacobio Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Sep 25, 2024 | clinicaltrials |
| NCT04713891 | A Study of KF-0210 in Advanced Solid Tumors Patients | completed | Phase 1 | 14 | Keythera Pharmaceuticals (Australia) Pty LtdINDUSTRY | 1 | Sep 24, 2024 | clinicaltrials |
| NCT02845479 | The Thoracic Peri-Operative Integrative Surgical Care Evaluation (POISE) Trial- Stage I(POISE) | completed | Phase 3 | 22 | The Canadian College of Naturopathic MedicineOTHER | 1 | Sep 20, 2024 | clinicaltrials |
| NCT04721223 | JAB-3068 Activity in Adult Patients With Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 12 | Jacobio Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Sep 19, 2024 | clinicaltrials |
| NCT01404156 | Preoperative Chemotherapy vs. Chemoradiation in Esophageal / GEJ Adenocarcinoma(POWERRANGER) | completed | Phase 2 / Phase 3 | 29 | Dr. Gordon BuduhanOTHER | 1 | Aug 28, 2024 | clinicaltrials |
| NCT06063941 | High-concentration Small-volume Versus Low-concentration Large-volume Iodine Solution for Esophageal Chromoendoscopy | completed | N/A | 450 | Xijing Hospital of Digestive DiseasesOTHER | 1 | Aug 27, 2024 | clinicaltrials |
| NCT06453993 | Temporal Variation in Exhaled Volatile Organic Compounds in Esophageal Cancer Patients | completed | N/A | 46 | Benaroya Research InstituteOTHER | 2 | Aug 27, 2024 | clinicaltrials |
| NCT03133286 | Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)(RADIANT) | completed | — | 16 | DxTerity DiagnosticsINDUSTRY | 1 | Aug 7, 2024 | clinicaltrials |
| NCT03490292 | Avelumab With Chemoradiation for Stage II/III Resectable Esophageal and Gastroesophageal Cancer | completed | Phase 1 / Phase 2 | 22 | University of Wisconsin, MadisonOTHER | 1 | Jul 26, 2024 | clinicaltrials |
| NCT04839471 | BI-754091 and Afatinib for Refractory Esophageal Squamous Cell Carcinoma (BEAR Study)(BEAR) | completed | Phase 2 | 49 | National Health Research Institutes, TaiwanOTHER | 1 | Jul 8, 2024 | clinicaltrials |
| NCT04435197 | Pre-Operative Pembrolizumab + Chemoradiation in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma(PALACE-2) | completed | Phase 2 | 143 | Ruijin HospitalOTHER | 1 | Jul 3, 2024 | clinicaltrials |
| NCT05542680 | Study on the Design and Application of Special Semi Recumbent Cushion for Postoperative Patients With Esophageal Cancer | completed | N/A | 134 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Jun 27, 2024 | clinicaltrials |
| NCT05688761 | Nordic Gastric and Esophageal Tumor Study(NordGETS) | completed | — | 900,000 | Karolinska InstitutetOTHER | 1 | Jun 24, 2024 | clinicaltrials |
| NCT06314516 | Influence of Nutrition and Sarcopenia on Esophageal Cancer Outcomes(INSPECT) | completed | — | 1,717 | Benaroya Research InstituteOTHER | 1 | May 24, 2024 | clinicaltrials |
| NCT06424210 | The Role of Surgery for Esophageal Cancer With Metastatic Disease (M1) | completed | — | 163 | National Taiwan University HospitalOTHER | 1 | May 22, 2024 | clinicaltrials |
| NCT04207918 | A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer | completed | Phase 2 | 55 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT05807542 | Neoadjuvant Immunotherapy Combined With Chemotherapy in Patients With Locally Advanced ESCC | completed | Phase 2 | 20 | Shanghai Zhongshan HospitalOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT06381583 | A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal Adenocarcinoma(EMERALD) | completed | — | 658 | City of Hope Medical CenterOTHER | 1 | May 10, 2024 | clinicaltrials |
| NCT03243734 | trūFreeze® Palliative Esophageal Cancer | completed | N/A | 49 | US Endoscopy Group Inc.INDUSTRY | 1 | May 8, 2024 | clinicaltrials |
| NCT04192695 | Esophageal Squamous Cell Cancer Surveillance With Cytosponge | completed | N/A | 178 | Centre of Postgraduate Medical EducationOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT05523960 | Mechanical Bowel Preparation Versus no Bowel Preparation for Esophageal Cancer Surgery | completed | N/A | 652 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | May 7, 2024 | clinicaltrials |
| NCT03165994 | APX005M With Concurrent Chemoradiation for Resectable Esophageal and Gastroesophageal Junction Cancers | completed | Phase 2 | 34 | Apexigen America, Inc.INDUSTRY | 1 | May 2, 2024 | clinicaltrials |
| NCT03468634 | Raman Probe for In-vivo Diagnostics (During Oesophageal) Endoscopy(RaPIDE) | completed | N/A | 25 | University of ExeterOTHER | 1 | Apr 25, 2024 | clinicaltrials |
| NCT05082948 | Migration Rates of Sutured vs Non-sutured Esophageal Stent Placement | completed | N/A | 46 | West Virginia UniversityOTHER | 1 | Apr 23, 2024 | clinicaltrials |
| NCT02129933 | VEGF-targeted Fluorescence Near-Infrared (NIR) Endoscopy in (Pre)Malignant Esophageal Lesions(VICE) | completed | Phase 1 | 14 | University Medical Center GroningenOTHER | 1 | Apr 16, 2024 | clinicaltrials |
| NCT03205501 | Molecular Fluorescence Endoscopy of (Pre)Malignant Esophageal Lesions(EAGLE) | completed | Phase 1 | 15 | University Medical Center GroningenOTHER | 1 | Apr 16, 2024 | clinicaltrials |
| NCT04656392 | Early Detection of Barrett's Esophagus in Participants With Reflux Symptoms in Primary Care(ELECTRONIC) | completed | N/A | 449 | Radboud University Medical CenterOTHER | 1 | Apr 16, 2024 | clinicaltrials |
| NCT03060642 | The Microenvironment in Barrett's Esophagus(BETRNet2) | completed | — | 155 | Columbia UniversityOTHER | 1 | Apr 5, 2024 | clinicaltrials |
| NCT04896242 | Multimodal Assesment of Acute Cardiac Toxicity Induced by Thoracic Radiotherapy in Cancer Patients | completed | — | 47 | Pontificia Universidad Catolica de ChileOTHER | 1 | Apr 4, 2024 | clinicaltrials |
| NCT03329950 | A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies | completed | Phase 1 | 132 | Celldex TherapeuticsINDUSTRY | 1 | Mar 28, 2024 | clinicaltrials |
| NCT02735239 | Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer | completed | Phase 1 / Phase 2 | 73 | Ludwig Institute for Cancer ResearchOTHER | 1 | Mar 22, 2024 | clinicaltrials |
| NCT04314349 | Radiogenomics in Aerodigestive Tract Cancers | completed | — | 139 | Buddhist Tzu Chi General HospitalOTHER | 1 | Mar 22, 2024 | clinicaltrials |
| NCT05030870 | Capnographic Monitoring in Gastrointestinal Endoscopy for Elderly Patients(CapnoGI) | completed | N/A | 1,800 | RenJi HospitalOTHER | 1 | Mar 19, 2024 | clinicaltrials |
| NCT03339843 | Multiorgan Metabolic Imaging Response Assessment of Abemaciclib(MiMe-A) | completed | Phase 2 | 85 | Jules Bordet InstituteOTHER | 2 | Mar 15, 2024 | clinicaltrials |
| NCT02812680 | The Utility of Circulating Tumour Cells and Plasma microRNA in Esophageal Adenocarcinoma | completed | — | 84 | University Health Network, TorontoOTHER | 1 | Mar 8, 2024 | clinicaltrials |
| NCT02497664 | Optimizing (Breathing) Techniques for Radiotherapy of Esophageal and Lung Carcinomas(ABC) | completed | N/A | 22 | University Medical Center GroningenOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT02839109 | PET-CT vs DWI-MRI in Response Evaluation in Esophageal Cancer(PET/MRI-EC) | completed | — | 26 | University Medical Center GroningenOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT05069766 | Preoperative Marking of the Oral Resection Margin in Esophageal Cancer With a Surgical Fiducial Marker - First Experiences | completed | N/A | 10 | Rigshospitalet, DenmarkOTHER | 1 | Feb 23, 2024 | clinicaltrials |
| NCT02830594 | Pembrolizumab and Palliative Radiation Therapy in Treating Patients With Metastatic Esophagus, Stomach, or Gastroesophageal Junction Cancer | completed | Phase 2 | 14 | City of Hope Medical CenterOTHER | 1 | Feb 20, 2024 | clinicaltrials |
| NCT05680077 | KCNA3 and OTOP2 Gene Methylation Combined Detection Kit (Fluorescent PCR Method) | completed | — | 1,116 | Wuhan Ammunition Life-tech Co., LtdINDUSTRY | 1 | Feb 13, 2024 | clinicaltrials |
| NCT01691625 | Concurrent Chemoradiation With or Without DC-CIK Immunotherapy in Treating Locally Advanced Esophageal Cancer | completed | N/A | 50 | Capital Medical UniversityOTHER | 1 | Feb 7, 2024 | clinicaltrials |
| NCT03549494 | Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric Junction | completed | Phase 2 | 45 | Catalysis SLINDUSTRY | 1 | Feb 7, 2024 | clinicaltrials |
| NCT06190652 | Real-world Experience of ICIs Plus Chemotherapy With or Without Radiotherapy for Advanced ESCC.(REICRAE) | completed | — | 728 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Feb 5, 2024 | clinicaltrials |
| NCT06241066 | The Prognostic Value of Tertiary Lymphatic Structure in Esophageal Squamous Cell Carcinoma | completed | — | 359 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Feb 5, 2024 | clinicaltrials |
| NCT06241079 | Multi-institutional Analysis of Survival and Recurrence Patterns of Different Pathological Regression Types After Neoadjuvant Chemoradiotherapy or Radiotherapy for Esophageal Squamous Cell Carcinoma | completed | — | 582 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | Feb 5, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Oct 26, 2024source: clinicaltrials